Today we have launched a new version of our website, as you can see. The updated version is more user-friendly with content and navigation clearly sorted by user groups (health care professionals, consumers, partners and investors) simplifying finding the information you are looking for. The studies and clinical documentation is now searchable by age group, field of interest and/or author.
Probiomax, the chewable tablet with Lactobacillus reuteri, is now also sold through Swedish pharmacies. The product trade dress on both the bottle label and box has changed and it now displays the BioGaia logotype. Read more about Probiomax, probiotics and Lactobacillus reuteri on Probiomax web site (in Swedish).
View this ABC local news story about baby Vincent, the BioGaia Drops and comments by Dr Rhoads, Houston, USA. Dr.Rhoads says it's too soon for researchers to recommend probiotic drops for colic, but if parents are desperate, he says it's safe to try them.
Laboratoires BIOETHIC recently launched BioGaia drops and tablets that are now available at pharmacies throughout France. BIOETHIC specialises in sales and marketing of pharmaceutical products and the BioGaia products have been well received by doctors in general and pediatricians in particular.
Look at interviews with clinical researchers Dr Ruggiero Francavilla, University of Bari, Italy; Dr Claudio Romano, University of Messina, Italy and Dr Alison Steiber, Case Western Reserve University, Cleveland, USA.
Scientists have obtained the first crystal (three-dimensional) structure of a mucus-binding protein (MUB) from a strain of Lactobacillus reuteri. They also found that these proteins recognise immunoglobulins, which participate in our immune defence. This knowledge can help to explain how the bacteria stick to the mucus layer in the gastrointestinal tract and enable it to maintain normal gut function.
A new study confirms that chewing gum from BioGaia containing Lactobacillus reuteri Prodentis reduces gingivitis (inflamed gums). The study also shows that the Lactobacillus reuteri Prodentis can interact directly with the human immune system to reduce inflammation.
Scientists have obtained the first crystal (three-dimensional) structure of a mucus-binding protein (MUB) from a strain of